Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2023

Open Access 18-04-2023 | Antipsychotics | Original Research: Qualitative Research

Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study

Authors: Natalia Jaworska, MD, MSc, Karla D. Krewulak, PhD, Emma Schalm, BKin/BCom, Daniel J. Niven, MD, MSc, PhD, Zahinoor Ismail, MD, Lisa D. Burry, PharmD, Jeanna Parsons Leigh, PhD, Kirsten M. Fiest, PhD

Published in: Journal of General Internal Medicine | Issue 10/2023

Login to get access

Abstract

Background

Antipsychotic medications do not alter the incidence or duration of delirium, but these medications are frequently prescribed and continued at transitions of care in critically ill patients when they may no longer be necessary or appropriate.

Objective

The purpose of this study was to identify and describe relevant domains and constructs that influence antipsychotic medication prescribing and deprescribing practices among physicians, nurses, and pharmacists that care for critically ill adult patients during and following critical illness.

Design

We conducted qualitative semi-structured interviews with critical care and ward healthcare professionals including physicians, nurses, and pharmacists to understand antipsychotic prescribing and deprescribing practices for critically ill adult patients during and following critical illness.

Participants

Twenty-one interviews were conducted with 11 physicians, five nurses, and five pharmacists from predominantly academic centres in Alberta, Canada, between July 6 and October 29, 2021.

Main Measures

We used deductive thematic analysis using the Theoretical Domains Framework (TDF) to identify and describe constructs within relevant domains.

Key Results

Seven TDF domains were identified as relevant from the analysis: Social/Professional role and identity; Beliefs about capabilities; Reinforcement; Motivations and goals; Memory, attention, and decision processes; Environmental context and resources; and Beliefs about consequences. Participants reported antipsychotic prescribing for multiple indications beyond delirium and agitation including patient and staff safety, sleep management, and environmental factors such as staff availability and workload. Participants identified potential antipsychotic deprescribing strategies to reduce ongoing antipsychotic medication prescriptions for critically ill patients including direct communication tools between prescribers at transitions of care.

Conclusions

Critical care and ward healthcare professionals report several factors influencing established antipsychotic medication prescribing practices. These factors aim to maintain patient and staff safety to facilitate the provision of care to patients with delirium and agitation limiting adherence to current guideline recommendations.
Appendix
Available only for authorised users
Literature
3.
go back to reference Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119-41.CrossRefPubMed Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30(1):119-41.CrossRefPubMed
22.
go back to reference Francis JJ, Stockton C, Eccles MP, Johnston M, Cuthbertson BH, Grimshaw JM, Hyde C, Tinmouth A, Stanworth SJ. Evidence-based selection of theories for designing behaviour change interventions: using methods based on theoretical construct domains to understand clinicians' blood transfusion behaviour. Br J Health Psychol. 2009;14(4):625-46. doi:doi: https://doi.org/10.1348/135910708X397025CrossRefPubMed Francis JJ, Stockton C, Eccles MP, Johnston M, Cuthbertson BH, Grimshaw JM, Hyde C, Tinmouth A, Stanworth SJ. Evidence-based selection of theories for designing behaviour change interventions: using methods based on theoretical construct domains to understand clinicians' blood transfusion behaviour. Br J Health Psychol. 2009;14(4):625-46. doi:doi: https://​doi.​org/​10.​1348/​135910708X397025​CrossRefPubMed
25.
go back to reference Stuart MM, Smith ZR, Payter KA, Martz CR, To L, Swiderek JL, et al. Pharmacist-driven discontinuation of antipsychotics for ICU delirium: A quasi-experimental study. JACCP Journal of the American College of Clinical Pharmacy. 2020;3(6):1009-14.CrossRef Stuart MM, Smith ZR, Payter KA, Martz CR, To L, Swiderek JL, et al. Pharmacist-driven discontinuation of antipsychotics for ICU delirium: A quasi-experimental study. JACCP Journal of the American College of Clinical Pharmacy. 2020;3(6):1009-14.CrossRef
Metadata
Title
Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study
Authors
Natalia Jaworska, MD, MSc
Karla D. Krewulak, PhD
Emma Schalm, BKin/BCom
Daniel J. Niven, MD, MSc, PhD
Zahinoor Ismail, MD
Lisa D. Burry, PharmD
Jeanna Parsons Leigh, PhD
Kirsten M. Fiest, PhD
Publication date
18-04-2023
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 10/2023
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-023-08042-5

Other articles of this Issue 10/2023

Journal of General Internal Medicine 10/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.